Notice of Intent to Award a Sole Source Contract to Biolog
HEALTH AND HUMAN SERVICES, DEPARTMENT OF.FOOD AND DRUG ADMINISTRATION.FOOD AND DRUG ADMINISTRATION
This opportunity closed July 9, 2026. 5 similar opportunities are open right now.
Similar opportunities open now
- NOTICE OF INTENT TO AWARD A SOLE SOURCEOpenDEPT OF DEFENSENo deadline listed
- Notice of Intent Sole Source Ansys, IncOpenDEPT OF DEFENSENo deadline listed
- Notice of Award Maintenance for Government owned BacT/ALERT 3D Equipment.OpenDEPT OF DEFENSECloses May 2028
- Notice of Intent to Award Sole Source to Hose-McCann CommunicationsOpenDEPT OF DEFENSENo deadline listed
- Notice of Intent to Award a Sole Source Contract – Sequencing Bundibugyo virus disease (BDBV) in the 2026 outbreakOpenHEALTH AND HUMAN SERVICES, DEPARTMENT OFNo deadline listed
About this archived opportunity
Notice of Intent to Award a Sole Source Contract to Biolog (FDA-133991) The Food and Drug Administration (FDA) intends to award a Sole Source firm-fixed price commercial Purchase Order (PO) to Biolog Inc. 21124 Cabot Blvd., Hayward, CA 94545 for the Purchase of Integrated Dual-Mode Microbial Phenotypic Analysis System in accordance with the authority under FAR RFO Part 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements. The NAICS Code for this action is 334516–Analytical Laboratory Instrument Manufacturing industry. This acquisition is being conducted using simplified acquisition procedures in accordance with FAR RFO Part 12 for the acquisition of commercial products and commercial services. Biolog is the only manufacturer of the Integrated Dual-Mode Microbial Phenotypic Analysis System that is uniquely capable of integrating with the FDA's existing maintaining compatibility with phenotypic microarray plates and validated workflows. Market research did not identify any alternative analyzers capable of providing an integrated platform that simultaneously measures redox respiration and optical density growth kinetics, compatibility with proprietary phenotypic microarray plates currently in use. This notice is not a request for competitive quotes. Any other firms desiring consideration must fully identify their interest and capability of meeting the requirements by submitting a capability statement to Janice Heard at janice.heard@fda.hhs.gov no later than July 09, 2026. Any response shall undergo review to determine if it can meet the requirements. A determination by the Government not to compete this proposed requirement based upon a response to this notice is solely within the discretion of the Government.
Historical details
- Status
- Closed
- Deadline
- July 9, 2026
- First captured
- June 25, 2026
- Publisher reference
- 7346aacbb6cc4bcc9670da57f15e66ce
Eligibility: No Set aside used
This opportunity has closed
Notice of Intent to Award a Sole Source Contract to Biolog
by HEALTH AND HUMAN SERVICES, DEPARTMENT OF.FOOD AND DRUG ADMINISTRATION.FOOD AND DRUG ADMINISTRATION
Get notified when similar opportunities open
We'll save this search and email you when new intent, sole, source opportunities are posted. Free.
Related opportunities
- NOTICE OF INTENT TO AWARD A SOLE SOURCEDEPT OF DEFENSE
- Notice of Intent Sole Source Ansys, IncDEPT OF DEFENSE
- NOTICE OF INTENT TO AWARD A SOLE SOURCEDEPT OF DEFENSE
- Notice of Award Maintenance for Government owned BacT/ALERT 3D Equipment.DEPT OF DEFENSECloses May 2028
- Notice of Intent to Award Sole Source to Hose-McCann CommunicationsDEPT OF DEFENSE
- Notice of Intent to Award a Sole Source Contract – Sequencing Bundibugyo virus disease (BDBV) in the 2026 outbreakHEALTH AND HUMAN SERVICES, DEPARTMENT OF